Versant Vantage I GP, L.P.

CIK 1777651 · last filed 2024-10-30

Versant Vantage I GP, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for GLUE, was dated Oct 30, 2024. Across all open-market trades the lifetime net is −$38.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $126.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$126.17M

Companies

4

Total Filings

6

Lifetime Open-Market Net

-$38.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
GLUE	10%+ Owner	5,720,827	$22.04	$126.09M	-$53.32M	2	2024-10-30
Oyster Point Pharma, Inc. (OYST) Delisted	10%+ Owner	0	$11.17	$0	$0	1	2023-01-04
Repare Therapeutics Inc. (RPTX) Delisted	10%+ Owner	2,977,733	$2.65	$7.89M	$0	2	2021-06-03
APRE	10%+ Owner	142,633	$0.61	$87.5K	$15.00M	1	2019-10-07

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-10-30	GLUE	Mixed	−9,266,112	-$8.95M	EDGAR
2024-09-24	GLUE	Sell (S)	−6,795,396	-$44.37M	EDGAR
2023-01-04	Oyster Point Pharma, Inc. (OYST) Delisted	U	−32,918,562	$0	EDGAR
2021-06-03	Repare Therapeutics Inc. (RPTX) Delisted	Other (J)	−225,000	$0	EDGAR
2021-05-07	Repare Therapeutics Inc. (RPTX) Delisted	Other (J)	−722,238	$0	EDGAR
2019-10-07	APRE	Mixed	+8,519,958	$15.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.